Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership52,572 shares
Latest Disclosed Value $ 406,382
Jpmorgan Chase & Co ownership in KUR / Kura Oncology, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 52,572 shares of Kura Oncology, Inc. (DE:KUR) valued at $349,604 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 40,101 shares of Kura Oncology, Inc.. This represents a change in shares of 31.10% during the quarter. The current value of the position is $397,444 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (KUR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:KUR / Kura Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 KURA ONCOLOGY COMMON 50127T109 52,572 12,471 31.10 406 -2.40 0.0000
2026-05-13 2026-03-31 13F KURA ONCOLOGY COMMON 50127T109 0 -100.00 0
2026-02-11 2025-12-31 13F KURA ONCOLOGY COMMON 50127T109 40,101 6,065 17.82 417 38.21 0.0000
2025-11-26 2025-09-30 13F/A-1 KURA ONCOLOGY COMMON 50127T109 34,036 -58,655 -63.28 301 -43.63 0.0000
2025-11-07 2025-09-30 13F KURA ONCOLOGY COMMON 50127T109 34,036 -58,655 301 0.0000
2025-08-12 2025-06-30 13F KURA ONCOLOGY COMMON 50127T109 92,691 -256,326 -73.44 535 -76.81 0.0000
2025-05-12 2025-03-31 13F KURA ONCOLOGY COMMON 50127T109 349,017 -16,904 -4.62 2,304 -27.74 0.0002
2025-02-12 2024-12-31 13F KURA ONCOLOGY COMMON 50127T109 365,921 -43,320 -10.59 3,187 -60.14 0.0002
2024-12-26 2024-09-30 13F/A-1 KURA ONCOLOGY COMMON 50127T109 409,241 3,092 0.76 7,997 -4.38 0.0006
2024-11-08 2024-09-30 13F KURA ONCOLOGY COMMON 50127T109 409,241 3,092 7,997 0.0006
2024-12-26 2024-06-30 13F/A-1 KURA ONCOLOGY COMMON 50127T109 406,149 -28,247 -6.50 8,363 -9.75 0.0007
2024-08-12 2024-06-30 13F KURA ONCOLOGY COMMON 50127T109 406,149 -28,247 8,363 0.0007
2024-12-26 2024-03-31 13F/A-1 KURA ONCOLOGY COMMON 50127T109 434,396 -38,596 -8.16 9,266 36.23 0.0008
2024-05-10 2024-03-31 13F KURA ONCOLOGY COMMON 50127T109 434,396 -38,596 9,266 0.0008
2024-12-26 2023-12-31 13F/A-1 KURA ONCOLOGY COMMON 50127T109 472,992 -8,877 -1.84 6,802 54.78 0.0007
2024-02-12 2023-12-31 13F KURA ONCOLOGY COMMON 50127T109 472,992 -8,877 6,802 0.0007
2023-11-14 2023-09-30 13F KURA ONCOLOGY COMMON 50127T109 481,869 -20,582 -4.10 4,395 -17.33 0.0005
2023-08-11 2023-06-30 13F KURA ONCOLOGY COMMON 50127T109 502,451 -10,771 -2.10 5,316 -15.33 0.0006
2023-05-18 2023-03-31 13F/A-1 KURA ONCOLOGY COMMON 50127T109 513,222 -691 -0.13 6,277 104,516.67 0.0008
2023-05-11 2023-03-31 13F KURA ONCOLOGY COMMON 50127T109 432,671 -81,242 6,277 0.0001
2023-02-13 2022-12-31 13F KURA ONCOLOGY COMMON 50127T109 513,913 -34,721 -6.33 6 -99.92 0.0008
2022-11-14 2022-09-30 13F KURA ONCOLOGY COMMON 50127T109 548,634 -12,966 -2.31 7,495 -27.19 0.0011
2022-08-11 2022-06-30 13F KURA ONCOLOGY COMMON 50127T109 561,600 480,848 595.46 10,294 692.46 0.0014
2022-05-11 2022-03-31 13F KURA ONCOLOGY COMMON 50127T109 80,752 -25,308 -23.86 1,299 -12.53 0.0002
2022-02-11 2021-12-31 13F/A-1 KURA ONCOLOGY COMMON 50127T109 106,060 50,547 91.05 1,485 42.93 0.0002
2022-02-10 2021-12-31 13F KURA ONCOLOGY COMMON 50127T109 106,060 50,547 1,485 0.0002
2021-11-12 2021-09-30 13F KURA ONCOLOGY COMMON 50127T109 55,513 -1,490 -2.61 1,039 -12.62 0.0001
2021-08-12 2021-06-30 13F KURA ONCOLOGY COMMON 50127T109 57,003 3,477 6.50 1,189 -21.47 0.0001
2021-05-12 2021-03-31 13F KURA ONCOLOGY COMMON 50127T109 53,526 -35,123 -39.62 1,514 -47.70 0.0002
2021-02-19 2020-12-31 13F/A-1 KURA ONCOLOGY COMMON 50127T109 88,649 50,549 132.67 2,895 148.71 0.0004
2021-02-11 2020-12-31 13F KURA ONCOLOGY COMMON 50127T109 88,649 50,549 2,895 71.5954
2020-11-12 2020-09-30 13F/A-1 KURA ONCOLOGY COMMON 50127T109 38,100 327 0.87 1,164 88.96 0.0002
2020-11-12 2020-09-30 13F KURA ONCOLOGY COMMON 50127T109 38,100 1,164
2020-08-11 2020-06-30 13F KURA ONCOLOGY COMMON 50127T109 37,773 4,162 12.38 616 83.88 0.0001
2020-05-12 2020-03-31 13F KURA ONCOLOGY COMMON 50127T109 33,611 -26,267 -43.87 335 -59.30 0.0001
2020-02-11 2019-12-31 13F KURA ONCOLOGY COMMON 50127T109 59,878 22,577 60.53 823 45.41 0.0002
2019-11-12 2019-09-30 13F KURA ONCOLOGY COMMON 50127T109 37,301 3,890 11.64 566 -14.37 0.0001
2019-08-07 2019-06-30 13F KURA ONCOLOGY COMMON 50127T109 33,411 26,508 384.01 661 474.78 0.0001
2019-05-07 2019-03-31 13F KURA ONCOLOGY COMMON 50127T109 6,903 -325 -4.50 115 13.86 0.0000
2019-02-11 2018-12-31 13F KURA ONCOLOGY COMMON 50127T109 7,228 675 10.30 101 -12.17 0.0000
2018-11-13 2018-09-30 13F/A-1 KURA ONCOLOGY COMMON 50127T109 6,553 1,506 29.84 115 25.00 0.0000
2018-11-07 2018-09-30 13F KURA ONCOLOGY COMMON 50127T109 6,553 1,506 115
2018-08-14 2018-06-30 13F KURA ONCOLOGY COMMON 50127T109 5,047 715 16.51 92 13.58 0.0000
2018-05-10 2018-03-31 13F KURA ONCOLOGY COMMON 50127T109 4,332 -723 -14.30 81 3.85 0.0000
2018-02-13 2017-12-31 13F KURA ONCOLOGY COMMON 50127T109 5,055 -50,416 -90.89 78 -90.27 0.0000
2017-11-09 2017-09-30 13F KURA ONCOLOGY COMMON 50127T109 55,471 55,471 802 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-12 2021-03-31 13F KURA ONCOLOGY OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A KURA ONCOLOGY OPTION Call 55,000 1,796 n/a n/a n/a
2021-02-11 2020-12-31 13F KURA ONCOLOGY OPTION Call 55,000 1,796 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-12 2021-03-31 13F KURA ONCOLOGY OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A KURA ONCOLOGY OPTION Put 6,600 216 n/a n/a n/a
2021-02-11 2020-12-31 13F KURA ONCOLOGY OPTION Put 6,600 216 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.